Hydroxyapatite Ca10(PO4)6(OH)2 crystal incorporation into bone matrix (osteoblast-mediated mineralization)
Cytosolic Ca2+ second messenger signaling via troponin C and calmodulin for skeletal/cardiac muscle excitation-contraction coupling
Voltage-gated Ca2+ channel-mediated synaptic vesicle exocytosis and neurotransmitter release at presynaptic terminals
Activation of coagulation factors (Factor IV) including prothrombin to thrombin conversion in the clotting cascade
Cofactor for digestive lipase and amylase enzyme function
Regulation of cell cycle checkpoint progression and differentiation via Ca2+/calmodulin-dependent kinases
Molecular + tissue targets
osteoblast
osteoclast
skeletal muscle fiber
cardiac myocyte
neuron presynaptic terminal
platelet coagulation cascade
enterocyte (intestinal absorption via TRPV6 and CaBP-9k)
Dosage range
Adults 19-50 y: 1000 mg/day elemental calcium (IOM RDA). Women >=51 y and adults >=71 y: 1200 mg/day. Pregnancy/lactation 19-50 y: 1000 mg/day. Upper Limit (UL): 2500 mg/day adults 19-50 y; 2000 mg/day adults >=51 y. Supplemental doses typically 500-600 mg per single dose (absorption saturation above ~500 mg). Best absorbed with vitamin D adequacy (>=600 IU/day, 800 IU/day for >=71 y).
Safety notes
Generally recognized as safe within UL. High supplemental doses (>2000 mg/d total) associated with hypercalcemia, milk-alkali syndrome, and possible nephrolithiasis (kidney stones) particularly in predisposed individuals. Cardiovascular safety of high-dose supplements (without vitamin D) remains debated; meta-analyses (Bolland et al.) suggested possible MI signal, but conclusion contested by NOF/ASBMR. Calcium impairs absorption of iron, zinc, levothyroxine, tetracyclines, fluoroquinolones, and bisphosphonates - separate dosing by 2-4 hours. Contraindicated in hypercalcemia, hypercalciuria, severe renal impairment, and active sarcoidosis without medical supervision. Calcium carbonate requires gastric acid for absorption (take with meals); calcium citrate absorbed with or without food and preferred in achlorhydria or PPI users.
Cross-market regulatory status
🇺🇸 FDA
FDA-authorized SSA (Significant Scientific Agreement) health claim under 21 CFR 101.72 "Health claims: calcium, vitamin D, and osteoporosis." Two regulatory tracks: (e) calcium-only model claim, (f) calcium + vitamin D + physical activity model claim added by 73 FR 56486 (Sept 29, 2008). Required disclosures and qualifying levels per 21 CFR 101.72(c). DSHEA structure/function claims (e.g., "supports bone health," "supports muscle function") permitted with FDA disclaimer under 21 USC 343(r)(6). GRAS as a nutrient (21 CFR 184.1191 calcium carbonate; 184.1193 calcium chloride; 184.1195 calcium citrate; etc.).
🇪🇺 EFSA
EFSA-evaluated and EU Commission-authorized under Regulation (EC) No 1924/2006 via Commission Regulation (EU) No 432/2012 Annex (List of permitted health claims). Eight authorized Article 13(1) function claims for calcium covering blood clotting, energy-yielding metabolism, muscle function, neurotransmission, function of digestive enzymes, cell division and specialisation, maintenance of normal bones, and maintenance of normal teeth. Use restricted to foods that are at least a "source of calcium" per the Annex to Regulation (EC) No 1924/2006 (>=15% NRV per 100 g/ml for solids, >=7.5% NRV per 100 ml for liquids).
🇧🇷 ANVISA
Permitted as nutrient ingredient in suplementos alimentares (dietary supplements) under ANVISA RDC 243/2018 (with composition limits per IN 28/2018 Anexos I, III, IV). Six authorized functional claims listed in IN 28/2018 Anexo V for "Cálcio," restricted to supplements meeting minimum quantity thresholds in Anexo III. Source/high-content nutrition claims permitted per IN 75/2020. Permitted in food enrichment per RDC 54/2012 and infant formula per RDC 43/2011 and RDC 44/2011.
Authorized claims · verbatim (17)
Direct quotes from each jurisdiction's framework · never paraphrased · with framework reference and conditions of use.
🇺🇸 FDA · 3 claims
21 CFR 101.72(e) - Health claims: calcium, vitamin D, and osteoporosis - calcium-only model
Adequate calcium throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis.
Conditions: Food must meet 21 CFR 101.72(c) qualifying levels: 20% or more of the DRV for calcium (i.e., >=200 mg) per RACC for the calcium-only claim; assimilable calcium; phosphorus content not exceeding calcium content; required disclosure for products containing >=400 mg per day of calcium that total intake >2,000 mg/day provides no added benefit.
21 CFR 101.72(f) - Health claims: calcium, vitamin D, and osteoporosis - calcium + vitamin D + physical activity model (added by 73 FR 56486, Sept 29, 2008)
Adequate calcium and vitamin D throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis.
Conditions: Per 21 CFR 101.72(c) and (f): food must contain >=20% DRV calcium per RACC; if claim references vitamin D, food must also contain >=20% DRV vitamin D per RACC; assimilable calcium; phosphorus content not exceeding calcium; appropriate disclosure of total intake limits.
21 CFR 101.72(f) - calcium + vitamin D + physical activity extended model
Adequate calcium and vitamin D as part of a healthful diet, along with physical activity, may reduce the risk of osteoporosis in later life.
Conditions: Same conditions as 21 CFR 101.72(c) and (f); requires food to meet calcium and vitamin D content qualifying levels and assimilability requirements.
🇪🇺 EFSA · 8 claims
Reg 432/2012
Calcium contributes to normal blood clotting
Conditions: The claim may be used only for food which is at least a source of calcium as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Calcium contributes to normal energy-yielding metabolism
Conditions: Food must be at least a source of calcium per Annex to Regulation (EC) No 1924/2006 (>=15% NRV per 100 g for solids; >=7.5% NRV per 100 ml for liquids).
Reg 432/2012
Calcium contributes to normal muscle function
Conditions: Food must be at least a source of calcium per Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Calcium contributes to normal neurotransmission
Conditions: Food must be at least a source of calcium per Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Calcium contributes to the normal function of digestive enzymes
Conditions: Food must be at least a source of calcium per Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Calcium has a role in the process of cell division and specialisation
Conditions: Food must be at least a source of calcium per Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Calcium is needed for the maintenance of normal bones
Conditions: Food must be at least a source of calcium per Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Calcium is needed for the maintenance of normal teeth
Conditions: Food must be at least a source of calcium per Annex to Regulation (EC) No 1924/2006.
🇧🇷 ANVISA · 6 claims
IN 28/2018 Anexo V alegação funcional
O cálcio auxilia na formação e manutenção de ossos e dentes.
Conditions: As alegações são restritas aos suplementos alimentares cuja quantidade de cálcio atenda aos valores mínimos estabelecidos no Anexo III desta Instrução Normativa.
Authorized 2018
IN 28/2018 Anexo V alegação funcional
O cálcio auxilia na coagulação do sangue.
Conditions: As alegações são restritas aos suplementos alimentares cuja quantidade de cálcio atenda aos valores mínimos estabelecidos no Anexo III desta Instrução Normativa.
Authorized 2018
IN 28/2018 Anexo V alegação funcional
O cálcio auxilia no funcionamento muscular.
Conditions: As alegações são restritas aos suplementos alimentares cuja quantidade de cálcio atenda aos valores mínimos estabelecidos no Anexo III desta Instrução Normativa.
Authorized 2018
IN 28/2018 Anexo V alegação funcional
O cálcio auxilia no funcionamento neuromuscular.
Conditions: As alegações são restritas aos suplementos alimentares cuja quantidade de cálcio atenda aos valores mínimos estabelecidos no Anexo III desta Instrução Normativa.
Authorized 2018
IN 28/2018 Anexo V alegação funcional
O cálcio auxilia no processo de divisão celular.
Conditions: As alegações são restritas aos suplementos alimentares cuja quantidade de cálcio atenda aos valores mínimos estabelecidos no Anexo III desta Instrução Normativa.
Authorized 2018
IN 28/2018 Anexo V alegação funcional
O cálcio auxilia no metabolismo energético.
Conditions: As alegações são restritas aos suplementos alimentares cuja quantidade de cálcio atenda aos valores mínimos estabelecidos no Anexo III desta Instrução Normativa.
